Australia's Sienna Cancer Diagnostics hits 18-mth high on appointing Swedish distributor
02/06/2020 03:10
** Shares of medical technology firm Sienna Cancer
Diagnostics SDX.AX rise as much as 5.3% to A$0.080, their
highest since Dec, 2018
** Co appoints Triolab AB, a unit of Sweden-based healthcare
firm AddLife AB ALIFb.ST as the exclusive distributor to sell
its hTERT product to Swedish pathology laboratories urn:newsml:reuters.com:*:nFWN2DE0VS
** Co says product can be used as an adjunct in urine
cytology, assisting pathologists in their diagnosis of bladder
cancer
** Stock set for sixth consecutive day of gains
** Stock up two-fold this year as of last close
(Reporting by Shriya Ramakrishnan in Bengaluru)
((Shriya.Ramakrishnan@thomsonreuters.com;))